PROCEPT BioRobotics (PRCT) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

PRCT Stock Forecast

PROCEPT BioRobotics stock forecast is as follows: an average price target of $105.00 (represents a 29.39% upside from PRCT’s last price of $81.15) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.

PRCT Price Target

The average price target for PROCEPT BioRobotics (PRCT) is $105.00 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $105.00 to $105.00. This represents a potential 29.39% upside from PRCT's last price of $81.15.

PRCT Analyst Ratings

Buy

According to 6 Wall Street analysts, PROCEPT BioRobotics's rating consensus is 'Buy'. The analyst rating breakdown for PRCT stock is 0 'Strong Buy' (0.00%), 5 'Buy' (83.33%), 1 'Hold' (16.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

PROCEPT BioRobotics Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Dec 02, 2024	Patrick Wood	Morgan Stanley	$105.00	$94.93	10.61%	29.39%
Oct 29, 2024	Richard Newitter	Truist Financial	$105.00	$96.24	9.10%	29.39%
Sep 03, 2024	Richard Newitter	Truist Financial	$95.00	$79.00	20.25%	17.07%
Jul 16, 2024	Richard Newitter	Truist Financial	$79.00	$68.90	14.66%	-2.65%
May 06, 2024	Matt O'Brien	Piper Sandler	$75.00	$64.31	16.62%	-7.58%
May 02, 2024	Richard Newitter	Truist Financial	$72.00	$60.61	18.79%	-11.28%
Sep 02, 2022	Nathan Treybeck	Wells Fargo	$49.00	$40.38	21.35%	-39.62%

The latest PROCEPT BioRobotics stock forecast, released on Dec 02, 2024 by Patrick Wood from Morgan Stanley, set a price target of $105.00, which represents a 10.61% increase from the stock price at the time of the forecast ($94.93), and a 29.39% increase from PRCT last price ($81.15).

PROCEPT BioRobotics Price Target by Period

	1M	3M	12M
# Anlaysts	1	2	6
Avg Price Target	$105.00	$105.00	$88.50
Last Closing Price	$81.15	$81.15	$81.15
Upside/Downside	29.39%	29.39%	9.06%

In the current month, the average price target of PROCEPT BioRobotics stock is $105.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 29.39% increase as opposed to PROCEPT BioRobotics's last price of $81.15. This month's average price target is down 0.00% compared to last quarter, and up 18.64% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Dec 02, 2024	Morgan Stanley		Overweight	Initialise
Oct 29, 2024	BTIG	Neutral	Neutral	Hold
Oct 28, 2024	William Blair	Outperform	Outperform	Hold
Oct 08, 2024	Truist Financial	Underperform	Underperform	Hold
Oct 08, 2024	Wells Fargo	Buy	Buy	Hold
Sep 16, 2024	Cowen & Co.	Buy	Buy	Hold
Jul 02, 2024	Cowen & Co.	Buy	Buy	Hold
May 06, 2024	Cowen & Co.	Buy	Buy	Hold
May 06, 2024	Piper Sandler	Overweight	Overweight	Hold

PROCEPT BioRobotics's last stock rating was published by Morgan Stanley on Dec 02, 2024. The company Initialise its PRCT rating from "null" to "Overweight".

PROCEPT BioRobotics Financial Forecast

PROCEPT BioRobotics Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$35.10M	$33.10M	$24.40M	$23.78M	$20.35M	$16.69M	$14.20M	$12.92M	$8.67M
Avg Forecast	$119.61M	$110.44M	$104.45M	$95.08M	$90.22M	$80.27M	$75.27M	$66.21M	$66.83M	$53.30M	$50.10M	$41.58M	$41.79M	$34.09M	$30.31M	$24.36M	$22.91M	$17.04M	$14.41M	$12.11M	$8.95M	$7.11M
High Forecast	$122.92M	$113.50M	$107.35M	$97.72M	$92.72M	$82.50M	$77.36M	$68.37M	$66.99M	$53.34M	$50.10M	$41.58M	$42.94M	$34.42M	$31.15M	$25.03M	$23.55M	$17.04M	$14.41M	$12.11M	$8.95M	$7.11M
Low Forecast	$117.54M	$108.53M	$102.65M	$93.44M	$88.66M	$78.89M	$73.97M	$64.38M	$66.66M	$53.27M	$50.10M	$41.58M	$41.06M	$33.77M	$29.79M	$23.94M	$22.52M	$17.04M	$14.41M	$12.11M	$8.95M	$7.11M
# Analysts	2	2	2	2	1	1	1	4	7	3	4	4	5	4	4	4	3	3	3	3	4	4
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.03%	1.09%	1.00%	1.04%	1.19%	1.16%	1.17%	1.44%	1.22%

PROCEPT BioRobotics's average Quarter revenue forecast for Dec 23 based on 5 analysts is $41.79M, with a low forecast of $41.06M, and a high forecast of $42.94M. PRCT's average Quarter revenue forecast represents a 19.04% increase compared to the company's last Quarter revenue of $35.10M (Sep 23).

PROCEPT BioRobotics EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
# Analysts	2	2	2	2	1	1	1	4	7	3	4	4	5	4	4	4	3	3	3	3	4	4
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	$-25.61M	$-24.32M	$-27.60M	$-24.05M	$-20.45M	$-17.03M	$-14.97M	$-40.59M	$-11.84M
Avg Forecast	$-112.91M	$-104.26M	$-98.61M	$-89.77M	$-85.18M	$-75.78M	$-71.06M	$-62.50M	$-63.09M	$-50.32M	$-47.30M	$-39.25M	$-39.45M	$-32.19M	$-28.62M	$-23.00M	$-21.63M	$-16.27M	$-13.75M	$-17.56M	$-8.55M	$-10.71M
High Forecast	$-110.96M	$-102.46M	$-96.91M	$-88.21M	$-83.70M	$-74.47M	$-69.84M	$-60.77M	$-62.93M	$-50.29M	$-47.30M	$-39.25M	$-38.77M	$-31.88M	$-28.12M	$-22.60M	$-21.26M	$-16.27M	$-13.75M	$-14.05M	$-8.55M	$-8.57M
Low Forecast	$-116.04M	$-107.15M	$-101.34M	$-92.25M	$-87.54M	$-77.88M	$-73.03M	$-64.55M	$-63.24M	$-50.35M	$-47.30M	$-39.25M	$-40.54M	$-32.49M	$-29.41M	$-23.63M	$-22.23M	$-16.27M	$-13.75M	$-21.07M	$-8.55M	$-12.85M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.80%	0.85%	1.20%	1.11%	1.26%	1.24%	0.85%	4.75%	1.11%

undefined analysts predict PRCT's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than PROCEPT BioRobotics's previous annual EBITDA (undefined) of $NaN.

PROCEPT BioRobotics Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
# Analysts	2	2	2	2	1	1	1	4	7	3	4	4	5	4	4	4	3	3	3	3	4	4
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$-24.62M	$-25.29M	$-27.70M	$-31.30M	$-23.12M	$-20.49M	$-18.67M	$-25.08M	$-14.10M
Avg Forecast	$-4.68M	$-8.32M	$-10.40M	$-9.88M	$-14.33M	$-16.26M	$-17.48M	$-17.35M	$-17.70M	$-25.41M	$-27.18M	$-28.88M	$-22.80M	$-27.33M	$-29.68M	$-30.25M	$-28.31M	$-24.84M	$-24.88M	$-20.11M	$-20.13M	$-12.76M
High Forecast	$-4.58M	$-8.14M	$-10.17M	$-9.66M	$-14.01M	$-15.90M	$-17.09M	$-11.20M	$-14.66M	$-24.84M	$-26.57M	$-28.23M	$-20.72M	$-26.72M	$-29.01M	$-29.57M	$-27.67M	$-24.84M	$-24.88M	$-16.09M	$-20.13M	$-10.21M
Low Forecast	$-4.85M	$-8.62M	$-10.78M	$-10.24M	$-14.85M	$-16.85M	$-18.11M	$-21.27M	$-22.25M	$-26.33M	$-28.16M	$-29.92M	$-25.91M	$-28.32M	$-30.75M	$-31.34M	$-29.33M	$-24.84M	$-24.88M	$-24.13M	$-20.13M	$-15.31M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.90%	0.85%	0.92%	1.11%	0.93%	0.82%	0.93%	1.25%	1.11%

PROCEPT BioRobotics's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. PRCT's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

PROCEPT BioRobotics SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
# Analysts	2	2	2	2	1	1	1	4	7	3	4	4	5	4	4	4	3	3	3	3	4	4
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$32.88M	$32.44M	$30.13M	$26.03M	$24.75M	$19.66M	$18.39M	$31.86M	$12.12M
Avg Forecast	$291.30M	$268.97M	$254.40M	$231.58M	$219.74M	$195.51M	$183.34M	$161.26M	$162.77M	$129.82M	$122.02M	$101.27M	$101.77M	$83.04M	$73.83M	$59.33M	$55.80M	$41.51M	$35.09M	$29.49M	$21.81M	$17.32M
High Forecast	$299.38M	$276.43M	$261.45M	$238.00M	$225.83M	$200.93M	$188.42M	$166.52M	$163.16M	$129.91M	$122.02M	$101.27M	$104.59M	$83.83M	$75.87M	$60.97M	$57.35M	$41.51M	$35.09M	$29.49M	$21.81M	$17.32M
Low Forecast	$286.27M	$264.33M	$250.01M	$227.58M	$215.95M	$192.13M	$180.17M	$156.79M	$162.35M	$129.74M	$122.02M	$101.27M	$100.01M	$82.25M	$72.55M	$58.30M	$54.84M	$41.51M	$35.09M	$29.49M	$21.81M	$17.32M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.40%	0.44%	0.51%	0.47%	0.60%	0.56%	0.62%	1.46%	0.70%

PROCEPT BioRobotics's average Quarter SG&A projection for Dec 23 is $101.77M, based on 5 Wall Street analysts, with a range of $100.01M to $104.59M. The forecast indicates a 209.50% rise compared to PRCT last annual SG&A of $32.88M (Sep 23).

PROCEPT BioRobotics EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
# Analysts	2	2	2	2	1	1	1	4	7	3	4	4	5	4	4	4	3	3	3	3	4	4
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.56	$-0.61	$-0.70	$-0.52	$-0.46	$-0.43	$-0.58	$-1.22
Avg Forecast	$-0.09	$-0.16	$-0.20	$-0.19	$-0.28	$-0.31	$-0.34	$-0.33	$-0.34	$-0.49	$-0.52	$-0.56	$-0.44	$-0.53	$-0.57	$-0.58	$-0.54	$-0.48	$-0.48	$-0.47	$-0.39	$-0.41
High Forecast	$-0.09	$-0.16	$-0.20	$-0.19	$-0.27	$-0.31	$-0.33	$-0.22	$-0.28	$-0.48	$-0.51	$-0.54	$-0.40	$-0.51	$-0.56	$-0.57	$-0.53	$-0.48	$-0.48	$-0.47	$-0.39	$-0.41
Low Forecast	$-0.09	$-0.17	$-0.21	$-0.20	$-0.29	$-0.32	$-0.35	$-0.41	$-0.43	$-0.51	$-0.54	$-0.58	$-0.50	$-0.54	$-0.59	$-0.60	$-0.56	$-0.48	$-0.48	$-0.47	$-0.39	$-0.41
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.98%	1.05%	1.29%	1.08%	0.95%	0.91%	1.49%	2.98%

According to undefined Wall Street analysts, PROCEPT BioRobotics's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to PRCT previous annual EPS of $NaN (undefined).

PROCEPT BioRobotics Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
LUNG	Pulmonx	$6.13	$13.00	112.07%	Buy
SGHT	Sight Sciences	$3.62	$7.50	107.18%	Hold
RXST	RxSight	$38.04	$70.14	84.38%	Buy
KIDS	OrthoPediatrics	$22.46	$39.50	75.87%	Buy
LIVN	LivaNova	$49.94	$68.25	36.66%	Buy
CNMD	CONMED	$71.23	$97.00	36.18%	Buy
OFIX	Orthofix Medical	$17.93	$24.00	33.85%
SIBN	SI-BONE	$13.84	$18.50	33.67%	Buy
NPCE	NeuroPace	$11.52	$15.00	30.21%	Buy
PRCT	PROCEPT BioRobotics	$88.56	$105.00	18.56%	Buy
ITGR	Integer	$136.68	$153.50	12.31%	Buy
FNA	Paragon 28	$10.36	$11.50	11.00%	Buy
ESTA	Establishment Labs	$44.67	$45.00	0.74%	Buy
SRDX	Surmodics	$39.96	$39.50	-1.15%	Buy

PRCT Forecast FAQ

Is PROCEPT BioRobotics a good buy?

Yes, according to 6 Wall Street analysts, PROCEPT BioRobotics (PRCT) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 83.33% of PRCT's total ratings.

What is PRCT's price target?

PROCEPT BioRobotics (PRCT) average price target is $105 with a range of $105 to $105, implying a 29.39% from its last price of $81.15. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will PROCEPT BioRobotics stock go up soon?

According to Wall Street analysts' prediction for PRCT stock, the company can go up by 29.39% (from the last price of $81.15 to the average price target of $105), up by 29.39% based on the highest stock price target, and up by 29.39% based on the lowest stock price target.

Can PROCEPT BioRobotics stock reach $120?

PRCT's average twelve months analyst stock price target of $105 does not support the claim that PROCEPT BioRobotics can reach $120 in the near future.

What is PROCEPT BioRobotics's current price target trend?

1 Wall Street analyst forecast a $105 price target for PROCEPT BioRobotics (PRCT) this month, up 29.39% from its last price of $81.15. Compared to the last 3 and 12 months, the average price target increased by 29.39% and increased by 9.06%, respectively.

What are PROCEPT BioRobotics's analysts' financial forecasts?

PROCEPT BioRobotics's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $311.98M (high $320.95M, low $305.9M), average EBITDA is $-295M (high $-289M, low $-303M), average net income is $-65.434M (high $-58.196M, low $-71.084M), average SG&A $759.84M (high $781.69M, low $745.03M), and average EPS is $-1.258 (high $-1.119, low $-1.367). PRCT's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $429.58M (high $441.48M, low $422.16M), average EBITDA is $-406M (high $-399M, low $-417M), average net income is $-33.287M (high $-32.54M, low $-34.485M), average SG&A $1.05B (high $1.08B, low $1.03B), and average EPS is $-0.64 (high $-0.626, low $-0.663).

Did the PRCT's actual financial results beat the analysts' financial forecasts?

Based on PROCEPT BioRobotics's last annual report (Dec 2023), the company's revenue was $136.19M, beating the average analysts forecast of $130.55M by 4.32%. Apple's EBITDA was $-109M, missing the average prediction of $-123M by -11.42%. The company's net income was $-106M, missing the average estimation of $-110M by -3.78%. Apple's SG&A was $131.77M, missing the average forecast of $317.97M by -58.56%. Lastly, the company's EPS was $0, missing the average prediction of $-2.116 by -100.00%. In terms of the last quarterly report (Sep 2023), PROCEPT BioRobotics's revenue was $35.1M, beating the average analysts' forecast of $34.09M by 2.96%. The company's EBITDA was $-25.609M, missing the average prediction of $-32.187M by -20.44%. PROCEPT BioRobotics's net income was $-24.622M, missing the average estimation of $-27.333M by -9.92%. The company's SG&A was $32.88M, missing the average forecast of $83.04M by -60.40%. Lastly, the company's EPS was $0, missing the average prediction of $-0.526 by -100.00%